Hillsdale Investment Management Inc. Baxter International Inc Transaction History

Hillsdale Investment Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$76.7 - $88.45 $7,670 - $8,845	-100 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$81.4 - $89.78 $537,240 - $592,548	-6,600 Reduced 98.51%	100 $9,000
Q1 2019 May 13, 2019	BUY	$64.48 - $81.31 $432,016 - $544,777	6,700 New	6,700 $544,000
Q4 2018 Feb 12, 2019	SELL	$61.45 - $77.8 $337,975 - $427,900	-5,500 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$63.43 - $75.41 $84,361 - $100,295	-1,330 Reduced 19.47%	5,500 $406,000
Q1 2018 May 14, 2018	SELL	$62.56 - $72.26 $18,768 - $21,678	-300 Reduced 4.21%	6,830 $444,000
Q4 2017 Feb 13, 2018	SELL	$61.45 - $66.05 $18,435 - $19,815	-300 Reduced 4.04%	7,130 $461,000
Q2 2017 Aug 14, 2017	BUY	N/A	7,430	7,430 $450,000

1,008

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.6B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.